The Health Resources and Services Administration (HRSA) recently published an FAQ responding to stakeholder questions about its contentious new 340B [...] …
Category: Federal
A federal appeals court recently scheduled late-October oral arguments for the pivotal legal battle over 340B rebate models, but hospitals [...] …
Several drugmakers recently announced refunds to 340B covered entities that purchased certain medications between 2019 and 2025, following recalculations of [...] …
A federal judge in Washington, D.C. has rejected a University of Alabama Health System lawsuit seeking interest on Medicare’s lump [...] …
An Indiana-based pharmaceutical giant recently announced that it’s working to align its U.S. drug prices with those paid by other [...] …
A Swiss pharmaceutical giant this week announced new 340B contract pharmacy restriction exemptions for two states that recently enacted contract [...] …
The dark money group behind a campaign targeting GOP-led states’ efforts to enact 340B contract pharmacy access laws recently released [...] …
Trade groups representing 340B hospitals and hospital pharmacists recently urged the Health Resources and Services Administration (HRSA) to extend the [...] …
A prestigious health care think tank recently offered an overview of the 340B program—including criticisms surrounding its growth and drugmakers’ [...] …
Two major drugmakers recently announced additional 340B contract pharmacy restriction exemptions for states that have enacted new contract pharmacy access [...] …